Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCK1 | P35558 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 4/20 | 0.32 |
| ▸ | HTR7 | P34969 | 4/20 | 0.32 |
| ▸ | SLC8A1 | P32418 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309712 | 1.00 | PCK1 (0.32) | PCK1HTR1AHTR7SLC8A1HTR6 | |
| SCHEMBL24310616 | 0.89 | HTR1A (0.34) | PCK1HTR1AHTR7SLC8A1HTR6 | |
| SCHEMBL29567020 | 0.89 | HTR1A (0.34) | PCK1HTR1AHTR7SLC8A1HTR6 | |
| SCHEMBL29566360 | 0.89 | HTR1A (0.33) | PCK1HTR1AHTR7HTR6DRD2 | |
| SCHEMBL24309314 | 0.89 | HTR1A (0.33) | PCK1HTR1AHTR7HTR6DRD2 | |
| SCHEMBL24310341 | 0.89 | SCN9A (0.38) | HTR1AHTR7SLC8A1HTR6DRD2 | |
| SCHEMBL29566911 | 0.89 | SCN9A (0.38) | HTR1AHTR7SLC8A1HTR6DRD2 | |
| SCHEMBL24309863 | 0.84 | HTR2C (0.38) | HTR1AHTR7HTR6 | |
| SCHEMBL29567148 | 0.84 | HTR2C (0.38) | HTR1AHTR7HTR6 | |
| SCHEMBL24309960 | 0.83 | PTK2 (0.32) | PCK1HTR1AHTR7SLC8A1HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225748-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |